logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5600.produswest2
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5600.produswest2
Antibiotic resistance, conflict and the Middle East | Collections | MSF Science Portal
Antibiotic resistance, conflict and the Middle East

Antibiotic resistance, conflict and the Middle East

Collection Content

Conference Material
|
Video

Impact of antimicrobial resistance in Middle Eastern settings

Truppa C, Ronat JB, Karah N, Shomar RA
2021-08-25 • MSF Scientific Days Asia 2021
2021-08-25 • MSF Scientific Days Asia 2021
Journal Article
|
Review

The socioeconomic burden of antibiotic resistance in conflict-affected settings and refugee hosting countries: a systematic scoping review

Kobeissi L, Menassa M, Mousally K, Repetto EC, Soboh I,  et al.
2021-04-06 • Conflict and Health
2021-04-06 • Conflict and Health
BACKGROUND
Antibiotic resistance (ABR) is a major global threat. Armed and protracted conflicts act as multipliers of infection and ABR, thus leading to increased healthcare and soci...
Journal Article
|
Commentary

Antibiotic resistance in conflict settings: lessons learned in the Middle East

Kanapathipillai R, Malou N, Hopman J, Bowman C, Yousef N,  et al.
2019-04-10 • Journal of Antimicrobial Chemotherapy
2019-04-10 • Journal of Antimicrobial Chemotherapy
Médecins Sans Frontières (MSF) has designed context-adapted antibiotic resistance (ABR) responses in countries across the Middle East. There, some health systems have been severely damag...
Journal Article
|
Research

Post-traumatic osteomyelitis in Middle East war-wounded civilians: resistance to first-line antibiotics in selected bacteria over the decade 2006-2016

Fily F, Ronat JB, Malou N, Kanapathipillai R, Seguin C,  et al.
2019-01-31 • BMC Infectious Diseases
2019-01-31 • BMC Infectious Diseases
BACKGROUND
War-wounded civilians in Middle East countries are at risk of post-traumatic osteomyelitis (PTO). We aimed to describe and compare the bacterial etiology and proportion of...
Journal Article
|
Research

Perceptions of healthcare-associated infection and antibiotic resistance among physicians treating Syrian patients with war-related injuries

Alga A, Karlow Herzog K, Alrawashdeh M, Wong S, Khankeh H,  et al.
2018-12-01 • International Journal of Environmental Research and Public Health
2018-12-01 • International Journal of Environmental Research and Public Health
Healthcare-associated infections (HAIs) constitute a major contributor to morbidity and mortality worldwide, with a greater burden on low- and middle-income countries. War-related injuri...
Journal Article
|
Letter

Antibiotic resistance in Palestine: an emerging part of a larger crisis

Kanapathipillai R, Malou N, Baldwin K, Marty P, Rodaix C,  et al.
2018-10-15 • British Medical Journal (BMJ)
2018-10-15 • British Medical Journal (BMJ)

See more collections

MSF logo
Sudan/Chad Disaster
No description available
Diabetes in humanitarian settings 2022
Diabetes in humanitarian settings 2022
No description available
Noma
Noma

Noma, also known as cancrum oris, is a rapidly progressing life-threatening infection that affects the mouth and face. Noma is preventable and easy to treat if addressed in the early reversible stages, but most often deadly if untreated. The disease most commonly affects children who are chronically malnourished or whose immune systems are otherwise compromised. Noma affects an estimated 140,000 children annually. Noma was added to the WHO's list of Neglected Tropical Diseases in 2023.


MSF is working to discover more about noma. This collection highlights MSF's mixed methods research on treatment outcomes, burden of disease, attitudes towards the disease and other aspects of noma.


For more information on MSF's work on noma, you can also visit https://noma.msf.org/.

View All Collections